scanX
Dr. Agarwal's Health Care
add_icon

Dr. Agarwal's Health Care

480.90
+1.30
(0.27%)
Market Cap
15,235.27 Cr
PE Ratio
90.43
Volume
32,657.00
Day High - Low
486.00 - 475.25
52W High-Low
568.00 - 327.00
ann
There are new updates from the company17 hrs ago
Viewcross
right
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
15,235.27 Cr
EPS
4.21
PE Ratio
90.43
PB Ratio
7.50
Book Value
63.90
EBITDA
569.57
Dividend Yield
0.00 %
Industry
Healthcare Services
Sector
Hospitals
Return on Equity
5.73
Debt to Equity
0.60
Analyst Rating and Forecast
- By Refinitiv from5 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+80.00 %
+80.00 %
Hold
Hold+20.00 %
+20.00 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
neutral
Dr. Agarwal's unit invests USD 2,00,00014 hrs ago
Orbit Healthcare Services (Mauritius) invested USD 2,00,000 in Orbit Health Care ETH PLC, making it a wholly owned subsidiary.
neutral
Dr. Agarwal's to meet investors4 days ago
Dr. Agarwal's Health Care Limited will hold investor meets from May 28 to June 16, 2026, in Mumbai, Singapore, and London.
positive
Dr. Agarwal's Health Care Q4 Profit Rises to 397M Rupees5 days ago
Dr. Agarwal's Health Care posts Q4 net profit of 397M rupees vs 325M YoY, with revenue rising to 5.64B rupees from 4.6B and EBITDA margin at 28.55%.
View more

Peer Comparison Compare Peers on Screener

Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
Apollo Hospitals
8,246.50
#1 1,18,572.02
59.30
#1 25,228.50
14.70
#1 2,032
33.00
63.72
Max Healthcare Institute
985.40
95,892.73
67.05
8,373.45
16.56
1,464
7.27
42.55
Fortis Healthcare
962.35
72,653.40
68.55
9,127.84
16.28
1,064
44.26
59.54
Narayana Hrudayalaya
1,912.60
39,086.05
47.95
7,896.04
#1 41.63
788
13.53
56.07
Aster DM Healthcare
746.40
38,672.55
91.98
4,643.22
8.32
384
#1 79.65
62.10
Global Health
1,207.00
32,443.00
59.59
4,410.27
16.94
584
39.64
61.14
Krishna Institute of Medical Sciences
765.00
30,610.63
126.90
3,904.60
27.31
198
-68.80
61.17
Dr. Agarwal's Health Care
480.90
#8 15,235.27
#8 90.43
#8 2,080.08
#3 18.39
#10 168
#7 17.65
65.17
Rainbow Childrens Medicare
1,350.10
13,711.50
49.27
1,703.08
8.69
262
38.41
67.78
Park Medi World
286.59
12,378.71
#1 45.42
1,679.36
17.77
272
46.56
77.79

Automatic Screeners on ScanX

Community
Resistance 1 Breached
Community
Support 1 Breached
Growth Rate
Revenue Growth
18.39 %
Net Income Growth
52.03 %
Cash Flow Change
4.14 %
ROE
-16.84 %
ROCE
-16.24 %
EBITDA Margin (Avg.)
-6.30 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Revenue
345
369
410
429
443
476
501
507
540
578
Expenses
244
241
300
310
316
332
360
363
386
403
EBITDA
101
128
110
119
128
144
141
144
155
175
Operating Profit %
27 %
31 %
26 %
26 %
27 %
28 %
26 %
27 %
27 %
29 %
Depreciation
43
47
56
57
58
60
63
68
69
77
Interest
22
27
27
28
28
25
25
23
21
22
Profit Before Tax
36
54
27
33
41
59
54
54
65
77
Tax
13
13
9
12
13
16
16
17
21
27
Net Profit
23
41
18
21
28
43
38
37
44
50
EPS in ₹
1.94
1.39
0.43
0.45
0.73
1.04
0.95
0.94
1.07
1.25
Above figures are in Rs. Crores

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
2026
Total Assets
752
787
1,026
1,825
2,753
3,672
3,942
Fixed Assets
551
575
702
1,293
1,746
2,523
2,378
Current Assets
146
155
228
310
759
794
573
Capital Work in Progress
8
11
28
99
118
153
234
Investments
1
0
0
34
471
264
94
Other Assets
193
201
296
399
418
731
0
Total Equity & Liabilities
752
787
1,026
1,825
2,753
3,672
3,942
Current Liabilities
146
150
206
301
400
478
462
Non Current Liabilities
339
438
586
865
974
1,267
1,361
Total Equity
267
199
234
659
1,380
1,927
2,026
Reserve & Surplus
242
177
206
622
1,330
1,835
1,994
Share Capital
7
7
7
8
9
32
32
Above figures are in Rs. Crores

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
2025
Net Cash Flow
-56
17
44
27
-15
-8
Investing Activities
-85
-46
-155
-509
-914
-750
Operating Activities
103
99
164
233
346
360
Financing Activities
-74
-37
35
303
553
382
Above figures are in Rs. Crores

Share Holding

% Holding
Sept 2024
Jan 2025
Feb 2025
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Mar 2026
Promoter
37.83 %
37.73 %
32.45 %
32.45 %
32.42 %
32.42 %
32.39 %
32.36 %
FIIs
0.00 %
0.00 %
56.97 %
60.62 %
59.26 %
58.13 %
58.06 %
57.94 %
DIIs
0.00 %
0.00 %
5.10 %
5.21 %
6.44 %
7.92 %
7.78 %
7.83 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
4.79 %
1.61 %
1.74 %
1.41 %
1.62 %
1.68 %
Others
62.17 %
62.27 %
0.69 %
0.11 %
0.14 %
0.11 %
0.15 %
0.19 %
No of Share Holders
29
43
2,17,289
68,696
63,021
48,168
46,554
43,538

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
14 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 14 Feb 2025 402.50 449.00
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 28 May 2025 401.60 375.25
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 12 Aug 2025 445.90 446.20
24 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
 24 Sept 2025 433.50 460.20
30 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 30 Oct 2025 542.55 510.35
03 Feb 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 03 Feb 2026 446.10 440.15
21 May 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
 21 May 2026 448.00 461.20

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition17 hrs ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome5 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS5 days ago
Announcement under Regulation 30 (LODR)-Investor Presentation5 days ago
Consolidated And Standalone Audited Financial Results Of The Company For The Quarter And Year Ended March 31 20265 days ago
Board Meeting Outcome for Consolidated And Standalone Audited Financial Results For The Quarter And Year Ended March 31 2026 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20155 days ago
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 20156 days ago
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2026
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015May 15, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 14, 2026
Board Meeting Intimation for Consideration And Approval Of The Audited Financial Results (Standalone And Consolidated) Of The Company For The Quarter And Year Ended March 31 2026May 14, 2026
Receipt Of Order Passed By The HonBle NCLT In Relation To The Scheme Of Amalgamation Between Dr. AgarwalS Eye Hospital Limited And Dr. AgarwalS Health Care LimitedMay 11, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSApr 08, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 06, 2026
Update On Announcement Under Regulation 30 (LODR) Dated February 03 2026Mar 30, 2026
Closure of Trading WindowMar 24, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 23, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 23, 2026
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Mar 23, 2026
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Mar 07, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 07, 2026
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Mar 05, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 27, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 27, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Feb 27, 2026
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Feb 25, 2026
Announcement under Regulation 30 (LODR)-Credit RatingFeb 23, 2026
Announcement under Regulation 30 (LODR)-Scheme of ArrangementFeb 17, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 12, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 10, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 04, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 03, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 03, 2026
Grant Of Options Under Dr. AgarwalS Health Care Limited - Employees Stock Option Scheme 2022Feb 03, 2026
Announcement under Regulation 30 (LODR)-Change in Registered Office AddressFeb 03, 2026
Consolidated And Standalone Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025.Feb 03, 2026
Board Meeting Outcome for Consolidated And Standalone Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025 And Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 03, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 30, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJan 28, 2026
Board Meeting Intimation for Considering And Approving The Standalone And Consolidated Unaudited Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Jan 28, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 12, 2026
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJan 06, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 03, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 03, 2026
Closure of Trading WindowDec 26, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportDec 19, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSDec 12, 2025

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Motilal Oswal BSE 1000 Index Fund Direct-Growth
0.02%
9
0.00%
-0.01%
Angel One Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Axis Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Aggressive Hybrid Fund Direct-Growth
0.66%
0
0.00%
0.01%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.24%
0
0.00%
0.00%
Bandhan Innovation Fund Direct-Growth
1.36%
0
0.00%
0.08%
Bandhan Large Cap Fund Direct-Growth
0.80%
0
0.00%
0.09%
Bandhan Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Bandhan Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
Canara Robeco Conservative Hybrid Fund Direct-Growth
0.08%
0
0.00%
0.00%
Canara Robeco Focused Fund Direct-Growth
0.93%
0
0.00%
0.01%
DSP Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
-0.02%
DSP Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
-0.18%
Edelweiss Aggressive Hybrid Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Equity Savings Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.97%
0
0.00%
-0.09%
Groww Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Groww Nifty Total Market Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
HDFC BSE 500 Index Fund Direct-Growth
0.02%
0
0.00%
0.00%
HDFC Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
HDFC Nifty500 Multicap 50:25:25 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Nifty 500 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
ICICI Prudential Nifty Smallcap 250 Index Fund Direct-Growth
0.00%
0
0.00%
0.00%
Invesco India Flexi Cap Fund Direct-Growth
0.92%
0
0.00%
-0.04%

Technical Indicators

RSI(14)
Neutral
65.17
ATR(14)
Less Volatile
15.31
STOCH(9,6)
Neutral
72.51
STOCH RSI(14)
Overbought
94.07
MACD(12,26)
Bullish
2.85
ADX(14)
Weak Trend
24.85
UO(9)
Bearish
52.57
ROC(12)
Uptrend And Accelerating
5.50
WillR(14)
Neutral
-28.34
Bearish
4
Neutral
3
Bullish
2
raisewe are part of Raise Financial Services
Heart
built with love

for indians who love to invest & trade

Explore   |   Sitemap
Fundamental Screeners
Technical Screeners
Intraday Screeners
Price & Volume Screeners
Candlestick Screeners
Bullish Stocks Today
Bearish Stocks Today
Stocks Nearing 52W High & Low
Rise & Fall Stocks
Index
Sector
Stock Heatmap
Companies
Sensex Companies
Nifty 50 Companies
Nifty Next 50 Companies
Nifty Bank Companies
Finnifty Companies
Defence Stocks
Semi Conductor Stocks
Renewable Energy Stocks
AI Stocks
Cement Stocks
Penny Stocks
Multibagger Stocks
Breakout Stocks
Dividend Stocks
Large Cap Stocks
Mid Cap Stocks
Small Cap Stocks
About Scanx

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.
As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.
We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.
This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.
The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.
We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.
This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.
By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.
We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

© 2025 - 2026 Raise Securities Pvt. Ltd. All rights reserved.

Part of Raise Financial Services

Registered Office: Unit No. 2201, 22nd Floor, Gold Medal Avenue, S.V. Road, Beside Patel Petrol Pump, Piramal Nagar, Goregaon West, Mumbai - 400104